Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 2 2Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 1Aspergillosis 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 901Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 433Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Micafungin × Clear all
NCT02440178 2021-11-09

Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia

Seoul National University Hospital

Phase 2 Completed
66 enrolled 8 charts
Other hematologic neoplasm

Leukemia

NCT01207128 2012-04-20

Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis

University of Arkansas

Phase 2 Withdrawn

Aspergillosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡